Document Detail


Effect of recent randomized trials on current pacing practice.
MedLine Citation:
PMID:  10348961     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The most common indication for a permanent pacemaker is symptomatic bradycardia. An atrial-based pacemaker (dual-chamber or atrial) usually is preferred, except in patients with chronic atrial fibrillation. Several prospective, randomized trials recently have been completed to evaluate new indications for permanent pacemakers. A dual-chamber pacemaker with an optimal atrioventricular interval can reduce the left ventricular outflow tract gradient by >50% in patients with hypertrophic cardiomyopathy. This has been associated with symptomatic improvement in the majority of patients, but an important placebo effect appears likely. Pacing also has been evaluated in patients with medically refractory dilated cardiomyopathy. Despite encouraging initial studies, routine implantation of a permanent pacemaker in dilated cardiomyopathy is not indicated. In patients with cardioinhibitory or mixed vasovagal syncope and carotid sinus hypersensitivity, implantation of a pacemaker markedly decreases syncopal episodes. Pacemaker therapy is clearly indicated in patients with atrial fibrillation associated with symptomatic bradycardia, and exciting new data on the use of pacing to prevent atrial fibrillation appear promising. The best pacing modality for this indication may be dual-site atrial pacing. Finally, permanent pacemakers play an important role in the treatment of symptomatic long QT syndrome, usually in combination with beta-blockers.
Authors:
A J Solomon; B J Gersh
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Cardiology in review     Volume:  7     ISSN:  1061-5377     ISO Abbreviation:  Cardiol Rev     Publication Date:    1999 Jan-Feb
Date Detail:
Created Date:  1999-11-30     Completed Date:  1999-11-30     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  9304686     Medline TA:  Cardiol Rev     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  9-16     Citation Subset:  IM    
Affiliation:
Division of Cardiology, Georgetown University Medical Center, Washington, DC 20007, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Atrial Fibrillation / etiology,  therapy
Cardiomyopathy, Dilated / etiology,  therapy
Cardiomyopathy, Hypertrophic / etiology,  therapy
Heart Diseases / etiology,  therapy*
Humans
Long QT Syndrome / etiology,  therapy
Pacemaker, Artificial*
Randomized Controlled Trials as Topic
Syncope, Vasovagal / etiology,  therapy
Treatment Outcome

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The Sexual Dimorphism of High Blood Pressure.
Next Document:  Evaluation of low-risk patients with chest pain in the emergency department: value and limitations o...